FDA Approved: ARIPIPRAZOLE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for aripiprazole from Ascend Laboratories, allowing a generic version to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Irritability Associated with Autistic Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)